AtCor sends investors' pulses racing
- {{x.value}}
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
We have sent you an email with the details of your registration.
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
- Verify your email address by clicking on the link we sent to {{user.Email}}
- You now have free access, we look forward to helping you on your financial journey.
AtCor Medical (ACG) share price enjoyed its second best one-day surge on record after it confirmed that it will report a maiden full year profit when it releases its results next month.
AtCor, which developed a blood pressure and arterial stiffness measuring device, said 2012-13 sales is expected to surge 40% to $9 million and full year profit will range between $2.7 million to $2.9 million.
This would put the stock on a very modest price-earnings multiple of under four times based on its last traded share price before the news, although the result was bolstered by a one-off research and development tax credit of $700,000 from the federal government.
However, its operating result is still encouraging as the company recorded a cash flow from operations of $600,000 for the period.
AtCor’s cash position is $2.9 million, which is more than double what it held in the bank a year ago.
But investors wouldn't be too surprised at the strong result if they had read Three small cap pocket rockets back in February.
The stock, which is not part of the Uncapped 100, jumped 43.8% to 10.5 cents in early trade. If it closes at this level, it would mark the stock’s best one-day jump since 2007.